trending Market Intelligence /marketintelligence/en/news-insights/trending/ZIvLqv6WJQH0wMKxWLfPvQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Getinge to acquire Applikon Biotechnology for 840M Swedish kronor

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Getinge to acquire Applikon Biotechnology for 840M Swedish kronor

Getinge AB agreed to acquire privately held Dutch company Applikon Biotechnology BV for 840 million Swedish kronor in cash.

Under the agreement, the Swedish healthcare company will purchase all of Applikon Biotechnology's outstanding common shares. Getinge could pay up to 630 million kronor in additional earnout fees in 2021-2022 upon the achievement of certain earnings performance in 2020-2021.

Getinge said it does not expect any material impact on its 2020 earnings.

The acquisition, which will be financed through debt, is expected to close during the first quarter of 2020.

Deutsche Bank is Getinge's exclusive financial adviser and NautaDutilh the legal adviser for the deal.

As of Dec. 18, US$1 was equivalent to 9.42 Swedish kronor.